viernes, 11 de octubre de 2019

A top FDA official weighs a future of individualized therapies

A top FDA official weighs a future of individualized therapies

Daily Recap

STAT Plus: After a bespoke therapy rescues a young girl, the FDA considers advance of individualized treatments

By MEGHANA KESHAVAN


COURTESY JULIA VITARELLO
The director of the FDA's Center for Drug Evaluation and Research says regulators are trying to determine how best to advance “N of 1” treatments.

No hay comentarios: